Seer, Inc. (California) (SEER)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Oct 16, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Seer Research and Development Expense (Annual) : 37.77M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 37.77M |
| December 31, 2024 | 44.41M |
| December 31, 2023 | 47.44M |
| December 31, 2022 | 45.80M |
| Date | Value |
|---|---|
| December 31, 2021 | 29.12M |
| December 31, 2020 | 17.34M |
| December 31, 2019 | 11.69M |
| December 31, 2018 | 3.676M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Champions Oncology, Inc. | 9.084M |
| Medpace Holdings, Inc. | -- |
| Avantor, Inc. | -- |
| Personalis, Inc. | 50.26M |
| Adaptive Biotechnologies Corp. | 83.81M |